The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.
about
The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implicationsInactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas.The Multifunctions of WD40 Proteins in Genome Integrity and Cell Cycle Progression.MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcomaTargeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells.
P2860
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@ast
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@en
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@nl
type
label
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@ast
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@en
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@nl
prefLabel
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@ast
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@en
The stress phenotype makes can ...... of the CRL4 ubiquitin ligase.
@nl
P2093
P2860
P50
P356
P1433
P1476
The stress phenotype makes can ...... r of the CRL4 ubiquitin ligase
@en
P2093
Daniela Dettori
Davide Zecchin
Erica Lantelme
P2860
P304
P356
10.18632/ONCOTARGET.2042
P407
P577
2014-08-01T00:00:00Z